Filiz Elbuken Celebi

9PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)OrthopaedicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 15, 2025
Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial.

Enver Özkurt, Cetin Ordu, Tolga Özmen

|Jan 02, 2025
Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance.

Zeynep Erdoğan İyigün, Tolga Ozmen, Serkan İlgün

|Jan 02, 2025
Artificial Intelligence in Diagnostic Breast Ultrasound: A Comparative Analysis of Decision Support Among Radiologists With Various Levels of Expertise.

Filiz Çelebi, Onur Tuncer, Müge Oral

|Apr 04, 2024
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy.

Tuba Kayan Tapan, Filiz Çelebi, Kourosh Yaghouti

|Aug 26, 2022
The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer.

Ahmet Serkan Ilgun, Fatma Aktepe, Onur Gonullu

|Jul 14, 2020
The Effect of Systemic Chemotherapy on Ovarian Function: A Prospective Clinical Trial.

Filiz Çelebi, Çetin Ordu, Serkan Ilgün

Pageof 2

Frequent Collaborators

7 joint publications

Tuba Kayan Tapan

6 joint publications

Çetin Ordu

6 joint publications

Serkan Ilgün

5 joint publications

Alper Oztürk